Cover Image
市場調查報告書

胰外分泌功能不全:全球臨床實驗趨勢

Exocrine Pancreatic Insufficiency Global Clinical Trials Review, H2, 2017

出版商 GlobalData 商品編碼 244190
出版日期 內容資訊 英文 79 Pages
訂單完成後即時交付
價格
Back to Top
胰外分泌功能不全:全球臨床實驗趨勢 Exocrine Pancreatic Insufficiency Global Clinical Trials Review, H2, 2017
出版日期: 2017年08月17日 內容資訊: 英文 79 Pages
簡介

本報告提供胰外分泌功能不全相關之臨床研究最新趨勢分析,提供您疾病·治療方法概要,及G7與E7各國的臨床實驗狀況,各地區、各階段的進行狀況,並彙整有潛力的贊助商,各企業及研究機關的研究進行狀況,有潛力的藥劑比較等資訊。

本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 主要國家的臨床實驗數量; 亞太地區
    • 前五名國家的臨床實驗數量; 歐洲
    • 主要國家的臨床實驗數量; 北美
    • 主要國家的臨床實驗數量; 中東/非洲地區
    • 主要國家的臨床實驗數量; 中南美

G7各國的臨床實驗數量:胰外分泌功能不全臨床實驗數量佔消化管疾病臨床實驗數量比率

各期臨床實驗數量: G7各國

G7各國的臨床實驗數量:各期

E7各國的臨床實驗數量:胰外分泌功能不全臨床實驗數量佔消化管疾病臨床實驗數量比率

各期臨床實驗數量: E7各國

E7各國的臨床實驗數量:各期

各期臨床實驗數量

  • 各期的進展中臨床實驗數量

各進展狀況臨床實驗數量

評估項目別臨床實驗數量

一定期間所採用的受驗人數

贊助商類別的臨床實驗數量

有潛力的贊助商

臨床實驗主要參加企業 - 胰外分泌功能不全治療藥

有潛力的藥劑

最新臨床實驗新聞:胰外分泌功能不全

臨床實驗簡介的基本資料

附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC4459CTIDB

GlobalData's clinical trial report, "Exocrine Pancreatic Insufficiency Global Clinical Trials Review, H2, 2017" provides an overview of Exocrine Pancreatic Insufficiency clinical trials scenario. This report provides top line data relating to the clinical trials on Exocrine Pancreatic Insufficiency. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents

Table of Contents 2

  • List of Tables 3
  • List of Figures 4
  • Report Guidance 5
  • GlobalData Clinical Trials Report Coverage 6
  • Clinical Trials by Region 7
  • Clinical Trials and Average Enrollment by Country 8
  • Top Countries Contributing to Clinical Trials in Asia-Pacific 11
  • Top Five Countries Contributing to Clinical Trials in Europe 12
  • Top Countries Contributing to Clinical Trials in North America 13
  • Top Countries Contributing to Clinical Trials in Middle East and Africa 14
  • Top Countries Contributing to Clinical Trials in Central and South America 15
  • Clinical Trials by G7 Countries: Proportion of Exocrine Pancreatic Insufficiency to Gastrointestinal Clinical Trials 16
  • Clinical Trials by Phase in G7 Countries 17
  • Clinical Trials in G7 Countries by Trial Status 18
  • Clinical Trials by E7 Countries: Proportion of Exocrine Pancreatic Insufficiency to Gastrointestinal Clinical Trials 19
  • Clinical Trials by Phase in E7 Countries 20
  • Clinical Trials in E7 Countries by Trial Status 21
  • Clinical Trials by Phase 22
  • In Progress Trials by Phase 23
  • Clinical Trials by Trial Status 24
  • Clinical Trials by End Point Status 25
  • Subjects Recruited Over a Period of Time 26
  • Clinical Trials by Sponsor Type 27
  • Prominent Sponsors 28
  • Top Companies Participating in Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials 30
  • Prominent Drugs 32
  • Latest Clinical Trials News on Exocrine Pancreatic Insufficiency 33
  • Jul 10, 2017: Anthera Pharmaceuticals Announces Phase 3 Clinical Study of Sollpura will be included in the Cystic Fibrosis Foundation Therapeutics Development Network 33
  • Jul 06, 2017: Anthera Announces Expansion of Screening in European Sites in Phase 3 RESULT Clinical Study of Sollpura 33
  • Clinical Trial Profile Snapshots 34

Appendix 77

  • Abbreviations 77
  • Definitions 77
  • Research Methodology 78
  • Secondary Research 78
  • About GlobalData 79
  • Contact Us 79
  • Source 79

List of Tables

List of Tables

  • Exocrine Pancreatic Insufficiency Therapeutics, Global, Clinical Trials by Region, 2017* 7
  • Exocrine Pancreatic Insufficiency Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 9
  • Exocrine Pancreatic Insufficiency Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 10
  • Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2017* 11
  • Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 12
  • Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials, North America, Top Countries, 2017* 13
  • Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2017* 14
  • Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials, Central and South America, Top Countries, 2017* 15
  • Proportion of Exocrine Pancreatic Insufficiency to Gastrointestinal Clinical Trials, G7 Countries (%), 2017* 16
  • Exocrine Pancreatic Insufficiency Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 17
  • Exocrine Pancreatic Insufficiency Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 18
  • Proportion of Exocrine Pancreatic Insufficiency to Gastrointestinal Clinical Trials, E7 Countries (%), 2017* 19
  • Exocrine Pancreatic Insufficiency Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 20
  • Exocrine Pancreatic Insufficiency Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 21
  • Exocrine Pancreatic Insufficiency Therapeutics, Global, Clinical Trials by Phase, 2017* 22
  • Exocrine Pancreatic Insufficiency Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 23
  • Exocrine Pancreatic Insufficiency Therapeutics, Global, Clinical Trials by Trial Status, 2017* 24
  • Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials, Global, by End Point Status, 2017* 25
  • Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 26
  • Exocrine Pancreatic Insufficiency Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 27
  • Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 29
  • Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 31
  • Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 32

List of Figures

List of Figures

  • Exocrine Pancreatic Insufficiency Therapeutics, Global, Clinical Trials by Region (%), 2017* 7
  • Exocrine Pancreatic Insufficiency Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 8
  • Exocrine Pancreatic Insufficiency Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 10
  • Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2017* 11
  • Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 12
  • Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 13
  • Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2017* 14
  • Proportion of Exocrine Pancreatic Insufficiency to Gastrointestinal Clinical Trials, G7 Countries (%), 2017* 16
  • Exocrine Pancreatic Insufficiency Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 17
  • Exocrine Pancreatic Insufficiency Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 18
  • Proportion of Exocrine Pancreatic Insufficiency to Gastrointestinal Clinical Trials, E7 Countries (%), 2017* 19
  • Exocrine Pancreatic Insufficiency Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 20
  • Exocrine Pancreatic Insufficiency Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 21
  • Exocrine Pancreatic Insufficiency Therapeutics, Global, Clinical Trials by Phase (%), 2017* 22
  • Exocrine Pancreatic Insufficiency Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 23
  • Exocrine Pancreatic Insufficiency Therapeutics, Global, Clinical Trials by Trial Status, 2017* 24
  • Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials, Global, by End Point Status, 2017* 25
  • Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 26
  • Exocrine Pancreatic Insufficiency Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 27
  • Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 28
  • Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 30
  • Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 32
  • GlobalData Methodology 78
Back to Top